Astellas announced that David Fryrear, M.S., joined its Medical and Development (M&D) organization as senior vice president and head of the Clinical and Research Quality Assurance (CRQA) organization in June 2019. 
 
Fryrear will be located at Astellas’ M&D headquarter office in Northbrook, Illinois, U.S., and will report directly to Zeiher. In his new role, Fryrear will be responsible for providing the global vision, leadership and strategic direction of CRQA at Astellas. 
 
Fryrear is a senior business leader with more than 30 years of experience in the pharmaceutical industry. He has a proven track record in developing and leading global teams that deliver proactive, effective and actionable strategies to support current and future pipelines by ensuring data is generated in a high quality, accurate and rigorous manner, in compliance with all relevant laws and regulations. Prior to joining Astellas, Fryrear held senior leadership roles at AbbVie and Eli Lilly in R&D Quality Assurance and Global Quality Systems.
 
“I am thrilled that David has joined Astellas to lead and provide strategic direction for our global CRQA organization,” said Bernhardt G. Zeiher, M.D., chief medical officer (CMO), Astellas. “David’s demonstrated skills and experience will ensure the delivery of robust and sustainable quality solutions, while allowing us the agility that we need to continue delivering innovative therapeutics to patients worldwide as fast as possible.”